Adagio Medical Holdings, Inc (ADGM)
Adagio Medical Holdings, Inc. focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. Its product portfolio includes ultra-low temperature cryoablation catheters and pulsed-field cryoablation catheter systems for cardiac arrhythmia treatment.
Company Info
Highlights
$21.53M
-$3.19
-$11.00K
-$639.00K
-$11.03M
$0.63 - $9.34
3.28%
2.93
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Adagio Medical Holdings, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading data...
Returns By Period
ADGM
- YTD
- 33.33%
- 1M
- 29.63%
- 6M
- 80.65%
- 1Y
- N/A
- 3Y*
- N/A
- 5Y*
- N/A
- 10Y*
- N/A
^GSPC (Benchmark)
- YTD
- 7.06%
- 1M
- 5.28%
- 6M
- 5.00%
- 1Y
- 14.38%
- 3Y*
- 16.95%
- 5Y*
- 14.32%
- 10Y*
- 11.51%
Monthly Returns
The table below presents the monthly returns of ADGM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Based on daily data since Aug 2024, the average daily return (also called the expected return) is -0.20%, while the average monthly return is -7.85%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 11.43% | -28.80% | -3.36% | 60.25% | -12.40% | 15.04% | 33.85% | 65.71% | |||||
| 2024 | -36.96% | -49.90% | 4.65% | -1.11% | -60.67% | -87.15% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Adagio Medical Holdings, Inc (ADGM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Adagio Medical Holdings, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Adagio Medical Holdings, Inc was 90.93%, occurring on Apr 4, 2025. The portfolio has not yet recovered.
The current Adagio Medical Holdings, Inc drawdown is 82.86%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.93% | Aug 5, 2024 | 168 | Apr 4, 2025 | — | — | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Adagio Medical Holdings, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Adagio Medical Holdings, Inc, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Adagio Medical Holdings, Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ADGM relative to other companies in the Medical Devices industry. Currently, ADGM has a P/S ratio of 37.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ADGM in comparison with other companies in the Medical Devices industry. Currently, ADGM has a P/B value of 1.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |